Condition: Femoral Arterial Calcification · Peripheral Arterial Disease · Claudication · Sponsor: Yale University
The primary goal of the study is to obtain effect size data on the use of Shockwave Intravascular Lithotripsy (IVL) technology in calcified common femoral lesions in patients with peripheral artery disease for a series of endpoints, including target lesion revascularization and health status, to enable future planning of comparative effectiveness research.
This description comes directly from the study's public registry record.
Kim Smolderen, PhD · 203-737-7673 · kim.smolderen@yale.edu
Always discuss trial participation with your own doctor first.
| Yale New Haven Health | New Haven, Connecticut, United States | Recruiting |
| The Miriam Hospital | Providence, Rhode Island, United States | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05145478